Literature DB >> 27339004

Subcellular organization of UBE3A in neurons.

Alain C Burette1, Matthew C Judson2, Susan Burette1, Kristen D Phend1, Benjamin D Philpot3, Richard J Weinberg4.   

Abstract

Ubiquitination regulates a broad array of cellular processes, and defective ubiquitination is implicated in several neurological disorders. Loss of the E3 ubiquitin-protein ligase UBE3A causes Angelman syndrome. Despite its clinical importance, the normal role of UBE3A in neurons is still unclear. As a step toward deciphering its possible functions, we performed high-resolution light and electron microscopic immunocytochemistry. We report a broad distribution of UBE3A in neurons, highlighted by concentrations in axon terminals and euchromatin-rich nuclear domains. Our findings suggest that UBE3A may act locally to regulate individual synapses while also mediating global, neuronwide influences through the regulation of gene transcription. J. Comp. Neurol. 525:233-251, 2017.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  Angelman syndrome; E6-AP; RRID:AB_10740376; RRID:nif-0000-30467; axon terminal; euchromatin; heterochromatin; mitochondria; ubiquitin-proteasome pathway

Mesh:

Substances:

Year:  2016        PMID: 27339004      PMCID: PMC5138109          DOI: 10.1002/cne.24063

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  71 in total

Review 1.  Ubiquitin in trafficking: the network at work.

Authors:  Filippo Acconcia; Sara Sigismund; Simona Polo
Journal:  Exp Cell Res       Date:  2008-10-28       Impact factor: 3.905

Review 2.  Ubiquitin-dependent endocytosis, trafficking and turnover of neuronal membrane proteins.

Authors:  Lindsay A Schwarz; Gentry N Patrick
Journal:  Mol Cell Neurosci       Date:  2011-08-22       Impact factor: 4.314

3.  Derangements of hippocampal calcium/calmodulin-dependent protein kinase II in a mouse model for Angelman mental retardation syndrome.

Authors:  Edwin J Weeber; Yong-Hui Jiang; Ype Elgersma; Andrew W Varga; Yarimar Carrasquillo; Sarah E Brown; Jill M Christian; Banefsheh Mirnikjoo; Alcino Silva; Arthur L Beaudet; J David Sweatt
Journal:  J Neurosci       Date:  2003-04-01       Impact factor: 6.167

4.  Administration of CoQ10 analogue ameliorates dysfunction of the mitochondrial respiratory chain in a mouse model of Angelman syndrome.

Authors:  Katrina J Llewellyn; Angèle Nalbandian; Arianna Gomez; Don Wei; Naomi Walker; Virginia E Kimonis
Journal:  Neurobiol Dis       Date:  2015-02-12       Impact factor: 5.996

5.  The human E6-AP gene (UBE3A) encodes three potential protein isoforms generated by differential splicing.

Authors:  Y Yamamoto; J M Huibregtse; P M Howley
Journal:  Genomics       Date:  1997-04-15       Impact factor: 5.736

6.  Dynamic developmental regulation of the large non-coding RNA associated with the mouse 7C imprinted chromosomal region.

Authors:  Elodie Le Meur; Françoise Watrin; Miguel Landers; Rachel Sturny; Marc Lalande; Françoise Muscatelli
Journal:  Dev Biol       Date:  2005-08-29       Impact factor: 3.582

7.  E6AP in the brain: one protein, dual function, multiple diseases.

Authors:  Jimmy El Hokayem; Zafar Nawaz
Journal:  Mol Neurobiol       Date:  2013-10-05       Impact factor: 5.590

8.  Autism genome-wide copy number variation reveals ubiquitin and neuronal genes.

Authors:  Joseph T Glessner; Kai Wang; Guiqing Cai; Olena Korvatska; Cecilia E Kim; Shawn Wood; Haitao Zhang; Annette Estes; Camille W Brune; Jonathan P Bradfield; Marcin Imielinski; Edward C Frackelton; Jennifer Reichert; Emily L Crawford; Jeffrey Munson; Patrick M A Sleiman; Rosetta Chiavacci; Kiran Annaiah; Kelly Thomas; Cuiping Hou; Wendy Glaberson; James Flory; Frederick Otieno; Maria Garris; Latha Soorya; Lambertus Klei; Joseph Piven; Kacie J Meyer; Evdokia Anagnostou; Takeshi Sakurai; Rachel M Game; Danielle S Rudd; Danielle Zurawiecki; Christopher J McDougle; Lea K Davis; Judith Miller; David J Posey; Shana Michaels; Alexander Kolevzon; Jeremy M Silverman; Raphael Bernier; Susan E Levy; Robert T Schultz; Geraldine Dawson; Thomas Owley; William M McMahon; Thomas H Wassink; John A Sweeney; John I Nurnberger; Hilary Coon; James S Sutcliffe; Nancy J Minshew; Struan F A Grant; Maja Bucan; Edwin H Cook; Joseph D Buxbaum; Bernie Devlin; Gerard D Schellenberg; Hakon Hakonarson
Journal:  Nature       Date:  2009-04-28       Impact factor: 49.962

9.  Novel submicroscopic chromosomal abnormalities detected in autism spectrum disorder.

Authors:  Susan L Christian; Camille W Brune; Jyotsna Sudi; Ravinesh A Kumar; Shaung Liu; Samer Karamohamed; Judith A Badner; Seiichi Matsui; Jeffrey Conroy; Devin McQuaid; James Gergel; Eli Hatchwell; T Conrad Gilliam; Elliot S Gershon; Norma J Nowak; William B Dobyns; Edwin H Cook
Journal:  Biol Psychiatry       Date:  2008-03-28       Impact factor: 13.382

10.  Integrated systems analysis reveals a molecular network underlying autism spectrum disorders.

Authors:  Jingjing Li; Minyi Shi; Zhihai Ma; Shuchun Zhao; Ghia Euskirchen; Jennifer Ziskin; Alexander Urban; Joachim Hallmayer; Michael Snyder
Journal:  Mol Syst Biol       Date:  2014-12-30       Impact factor: 11.429

View more
  24 in total

1.  UBE3A regulates the transcription of IRF, an antiviral immunity.

Authors:  Ryohei Furumai; Kota Tamada; Xiaoxi Liu; Toru Takumi
Journal:  Hum Mol Genet       Date:  2019-06-15       Impact factor: 6.150

2.  Decreased Axon Caliber Underlies Loss of Fiber Tract Integrity, Disproportional Reductions in White Matter Volume, and Microcephaly in Angelman Syndrome Model Mice.

Authors:  Matthew C Judson; Alain C Burette; Courtney L Thaxton; Alaine L Pribisko; Mark D Shen; Ashley M Rumple; Wilmer A Del Cid; Beatriz Paniagua; Martin Styner; Richard J Weinberg; Benjamin D Philpot
Journal:  J Neurosci       Date:  2017-06-29       Impact factor: 6.167

Review 3.  Cerebral organoids as an in vitro model to study autism spectrum disorders.

Authors:  Alexa Rabeling; Mubeen Goolam
Journal:  Gene Ther       Date:  2022-07-05       Impact factor: 5.250

4.  Adult Ube3a Gene Reinstatement Restores the Electrophysiological Deficits of Prefrontal Cortex Layer 5 Neurons in a Mouse Model of Angelman Syndrome.

Authors:  Diana C Rotaru; Geeske M van Woerden; Ilse Wallaard; Ype Elgersma
Journal:  J Neurosci       Date:  2018-08-06       Impact factor: 6.167

5.  Neuronal overexpression of Ube3a isoform 2 causes behavioral impairments and neuroanatomical pathology relevant to 15q11.2-q13.3 duplication syndrome.

Authors:  Nycole A Copping; Sarah G B Christian; Dylan J Ritter; M Saharul Islam; Nathalie Buscher; Dorota Zolkowska; Michael C Pride; Elizabeth L Berg; Janine M LaSalle; Jacob Ellegood; Jason P Lerch; Lawrence T Reiter; Jill L Silverman; Scott V Dindot
Journal:  Hum Mol Genet       Date:  2017-10-15       Impact factor: 6.150

Review 6.  Abnormalities of synaptic mitochondria in autism spectrum disorder and related neurodevelopmental disorders.

Authors:  Liliana Rojas-Charry; Leonardo Nardi; Axel Methner; Michael J Schmeisser
Journal:  J Mol Med (Berl)       Date:  2020-12-18       Impact factor: 4.599

7.  Loss of nuclear UBE3A activity is the predominant cause of Angelman syndrome in individuals carrying UBE3A missense mutations.

Authors:  Stijn N V Bossuyt; A Mattijs Punt; Ilona J de Graaf; Janny van den Burg; Mark G Williams; Helen Heussler; Ype Elgersma; Ben Distel
Journal:  Hum Mol Genet       Date:  2021-04-30       Impact factor: 6.150

Review 8.  UBE3A reinstatement as a disease-modifying therapy for Angelman syndrome.

Authors:  Ype Elgersma; Monica Sonzogni
Journal:  Dev Med Child Neurol       Date:  2021-02-04       Impact factor: 5.449

9.  Enhanced Transmission at the Calyx of Held Synapse in a Mouse Model for Angelman Syndrome.

Authors:  Tiantian Wang; Geeske M van Woerden; Ype Elgersma; J Gerard G Borst
Journal:  Front Cell Neurosci       Date:  2018-01-04       Impact factor: 5.505

10.  Activity-Dependent Arc Expression and Homeostatic Synaptic Plasticity Are Altered in Neurons from a Mouse Model of Angelman Syndrome.

Authors:  Elissa D Pastuzyn; Jason D Shepherd
Journal:  Front Mol Neurosci       Date:  2017-07-28       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.